Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unicancer is the French federation of Comprehensive Cancer Centers (FCCC), a network of 18 private, non-profit hospitals exclusively dedicated to oncology. It operates as a major academic sponsor of clinical trials in Europe, coordinating research efforts across its member centers to advance cancer treatment and patient care. The organization plays a pivotal role in precision medicine and the evaluation of innovative therapies, including immunotherapies and targeted agents. By bridging the gap between clinical research and hospital practice, Unicancer facilitates large-scale multicenter studies in partnership with the global pharmaceutical industry. Through its R&D department, it provides comprehensive clinical research services, including trial design, regulatory management, and data analysis. Unicancer represents a unique model of integrated care, research, and teaching, ensuring that patients have access to the latest medical innovations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FNCLCC.